Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study

BACKGROUND: Granulocyte and monocyte adsorptive apheresis (GMA) is widely used as a remission induction therapy for active ulcerative colitis (UC) patients. However, there are no available biomarkers for predicting the clinical outcome of GMA. We investigated the utility of Fecal calprotectin (FC) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Nobuhiro, Sugiyama, Yuya, Kobayashi, Yu, Murakami, Yuki, Iwama, Takuya, Sasaki, Takahiro, Kunogi, Takehito, Takahashi, Keitaro, Tanaka, Kazuyuki, Ando, Katsuyoshi, Kashima, Shin, Inaba, Yuhei, Moriichi, Kentaro, Tanabe, Hiroki, Taruishi, Masaki, Saitoh, Yusuke, Okumura, Toshikatsu, Fujiya, Mikihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348877/
https://www.ncbi.nlm.nih.gov/pubmed/34362299
http://dx.doi.org/10.1186/s12876-021-01889-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348877/
https://www.ncbi.nlm.nih.gov/pubmed/34362299
http://dx.doi.org/10.1186/s12876-021-01889-0

Ejemplares similares